Ignite Creation Date:
2025-12-26 @ 11:07 AM
Ignite Modification Date:
2026-07-01 @ 9:23 AM
Study NCT ID:
NCT06548412
Status:
RECRUITING
Last Update Posted:
2025-07-25
First Post:
2024-08-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Biliary Tract Cancer | View |
Keywords: